| Ytd | -9.72% | |
| 1y | 36.34% |
| Open | 6.04 | Prev Close | 6.04 | Low | 6.04 | High | 6.04 | Mkt Cap | 27.24M |
| Vol | 353.00 | Avg Vol | 23.60K | EPS | -0.36 | P/E | -16.78 | Forward P/E | 14.00 |
| Beta | 1.49 | Short Ratio | 2.66 | Inst. Own | 75.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 6.02 | 200-d Avg | 5.87 | 1yr Est | 6.25 |
On May 25, 2026, the Board of Directors (the "Board") of LENSAR, Inc. (the "Company"
Harvard Bioscience, Inc. (HBIO) Q1 2026 Earnings Call Transcript
First Quarter 2026 Revenues of $20.8M and Gross Margin of 59% Consolidation of Manufacturing Operati
HOLLISTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today ann
HOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will an
Harvard Bioscience (NASDAQ: HBIO) executives highlighted a year of "foundation building" and cost an
Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript
Fourth Quarter 2025 Revenues of $23.7M and Gross Margin of 59.7% Full Year 2025 Revenues of $86.6M a
Harvard Bioscience's common stock is expected to begin trading on a post-split adjusted basis on Mar
Harvard Bioscience, Inc. (NASDAQ: HBIO - Get Free Report)'s stock price passed above its two hundred
HOLLISTON, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today a
HOLLISTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will ann
Shares of Harvard Bioscience, Inc. (NASDAQ: HBIO - Get Free Report) crossed below its 200-day moving
Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidan
Streamlining production footprint and improving manufacturing efficiency through phased closure of H
Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flex
Harvard Bioscience, Inc. (NASDAQ: HBIO - Get Free Report) shares crossed above its two hundred day m
Former Treasury Secretary Larry Summers said he was stepping back from all public commitments amid f
Harvard Bioscience, Inc. ( HBIO ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Partici
Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by Operations
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will ann
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for
Monday saw 825 companies set new 52-week lows.